GSK Unveils $2 Billion Share Buyback Amid Surprising Profit Surge
17 days ago
In an impressive move signaling confidence in its future prospects, GlaxoSmithKline (GSK) has announced a substantial $2 billion share buyback program. This decision follows a robust financial performance that surpassed analysts’ expectations, indicating a potential shift in the company's trajectory.
Continue reading